(−)-Epigallocatechin-3-gallate (EGCG) ameliorates ovalbumin-induced asthma by inhibiting inflammation via the TNF-α/TNF-R1/NLRP3 signaling pathwayBeibei Zhang, Weisheng Feng, Yuanyuan Wu et al.|International Immunopharmacology|2024Cited by 17